FutureChem Co.,Ltd акциялары

FutureChem Co.,Ltd is a South Korean company dedicated to the creation and distribution of radiopharmaceutical products. Its current offerings include PDVUE, a positron emission tomography (PET) diagnostic agent for Parkinson's disease; Alzavue, used in the diagnosis of Alzheimer's disease; and [18F]FDG, a PET radiopharmaceutical primarily employed in cancer therapy. The company's development pipeline is robust, featuring 18F-FC303, a PET diagnostic for prostate cancer; 177Lu-FC705, targeting prostate cancer treatment; 18F-FMT, aimed at brain tumors; 18F-FC505, designed for atherosclerotic plaque; and 18F-FC211, another prospective treatment for Alzheimer's disease. Founded in 1999, FutureChem Co.,Ltd is headquartered in Seoul, South Korea.